Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Signaling Pathway >> Calcium Signaling >> Other
Anti-KCNJ1 antibody
See all KCNJ1 products (5) ...
Rabbit polyclonal to KCNJ1
Reacts with
Human
Predicted to work with
Mouse, Rat, Dog, Zebrafish
Synthetic peptide corresponding to a region within internal sequence amino acids 216-265 (LRKSLLIGSH IYGKLLKTTV TPEGETIILD QININFVVDA GNENLFFISP) of Human KCNJ1 (NP_000211).
LRKSLLIGSH IYGKLLKTTV TPEGETIILD QININFVVDA GNENLFFISP
HepG2 cell lysate.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Preservative: None
Constituents: 2% Sucrose, PBS
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Signal Transduction >> Metabolism >> Plasma Membrane >> Channels
Signal Transduction >> Signaling Pathway >> Calcium Signaling >> Other
Western blot - KCNJ1 antibody (ab85479)
(enlarge)
Our Abpromise guarantee covers the use of ab85479 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 1 µg/mlPredicted molecular weight: 45 kDa.
In the kidney, probably plays a major role in potassium homeostasis. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This channel is activated by internal ATP and can be blocked by external barium.
In the kidney and pancreatic islets. Lower levels in skeletal muscle, pancreas, spleen, brain, heart and liver.
Defects in KCNJ1 are the cause of Bartter syndrome type 2 (BS2) [MIM:241200]; also termed hyperprostanglandin E syndrome 2. BS refers to a group of autosomal recessive disorders characterized by impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and varying degrees of hypercalciuria. BS2 is a life-threatening condition beginning in utero, with marked fetal polyuria that leads to polyhydramnios and premature delivery. Another hallmark of BS2 is a marked hypercalciuria and, as a secondary consequence, the development of nephrocalcinosis and osteopenia.
Belongs to the inward rectifier-type potassium channel (TC 1.A.2.1) family. KCNJ1 subfamily.
Membrane.
Target information above from: UniProt accessionP48048
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - KCNJ1 antibody (ab85479)

Anti-KCNJ1 antibody (ab85479) at 1 µg/ml (in 5% skim milk / PBS buffer) + HepG2 cell lysate at 10 µg
Secondary
HRP conjugated anti-Rabbit IgG at 1/50000 dilution
Predicted band size : 45 kDa
Observed band size : 45 kDa
Gel concentration: 12%
ab85479 has not yet been referenced specifically in any publications.
Publishing research using ab85479? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
